Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Jan 3, 2014

29777_dirs_2014-01-03_fba8003a-7586-4230-8a54-f6d831fdcd70.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2013-12-19

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-19 Common shares without par value G 1710 Disposed 1387542 Direct
2013-12-19 Common shares without par value G 350 Acquired 7643 Indirect
2013-12-19 Common shares without par value G 350 Acquired 7552 Indirect
2013-12-19 Common shares without par value G 660 Acquired 660 Indirect
2013-12-20 Common shares without par value G 660 Disposed 0 Indirect
2013-12-20 Common shares without par value G 220 Acquired 7863 Indirect
2013-12-20 Common shares without par value G 220 Acquired 7772 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 25462 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 19, 2013.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.